Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 diciembre 2012

TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY. Radiological Anatomy of Prostatic Arteries

Tiago Bilhim, MD, PhD, EBIR, Hugo Rio Tinto, MD, Lúcia Fernandes, MD, João Martins Pisco, MD, PhD

One of the most challenging aspects of prostatic arterial embolization for patients with lower urinary tract symptoms and prostate enlargement or benign prostatic hyperplasia is identifying the prostatic arteries (PAs). With preprocedural computed tomography angiography it is possible to plan treatment and exclude patients when arterial anatomy is not suited, or when extensive atherosclerotic changes may affect technical success.

01 diciembre 2012

TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY. Patient Selection and Counseling before Prostatic Arterial Embolization

José A. Pereira, MD, Tiago Bilhim, MD, PhD, EBIR, Marisa Duarte, MD, Hugo Rio Tinto, MD, Lúcia Fernandes, MD, João Martins Pisco, MD, PhD

Prostatic arterial embolization (PAE) for relief of lower urinary tract symptoms (LUTS) in patients with prostate enlargement or benign prostatic hyperplasia (PE or BPH) is an experimental procedure with promising preliminary results.

01 diciembre 2012

CVIR. Chemoembolic Hepatopulmonary Shunt Reduction to Allow Safe Yttrium-90 Radioembolization Lobectomy of Hepatocellular Carcinoma

Ron C. Gaba, Kyle A. VanMiddlesworth

Abstract Yttrium-90 (90Y) radioembolization represents an emerging transcatheter treatment option for the management of hepatocellular carcinoma (HCC). Elevation of the hepatopulmonary shunt fraction risks nontarget radiation to the lungs and may limit the use of 90Y therapy in patients with locally advanced disease with vascular invasion, who often demonstrate increased shunting. We present two cases in which patients with HCC and portal vein invasion resulting in elevated hepatopulmonary shunt fractions underwent chemoembolic shunt closure to allow safe 90Y radioembolization. Both patients demonstrated excellent tumor response and patient survival. On this basis, we propose a role for chemoembolic reduction of the lung shunt fraction before 90Y radioembolization in patients with extensive tumor-related hepatopulmonary shunting. CardioVascular and Interventional Radiology December 2012, Volume 35, Issue 6, pp 1505-1511. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012

01 octubre 2012

CVIR. Hepatic Toxicity After Radioembolization of the Liver Using 90Y-Microspheres: Sequential Lobar Versus Whole Liver Approach

Ricarda Seidensticker, Max Seidensticker, Robert Damm, Konrad Mohnike, Kerstin Schütte, Peter Malfertheiner, Mark Van Buskirk, Maciej Pech, Holger Amthauer, Jens Ricke

Purpose: 90Y-radioembolization (RE) is a promising technique for delivering high doses of radiation to liver tumors but may result in compromise of liver function. To gain further perspective, we evaluated the toxicity rates of sequential lobar versus “whole liver” 90Y-radioembolization. CardioVascular and Interventional Radiology October 2012, Volume 35, Issue 5, pp 1109-1118. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

01 octubre 2012

CVIR. Serum Gamma-Glutamyl-Transferase Independently Predicts Outcome After Transarterial Chemoembolization of Hepatocellular Carcinoma: External Validation

Boris Guiu, Frédéric Deschamps, Mathieu Boulin, Valérie Boige, David Malka, Michel Ducreux, Patrick Hillon, Thierry de Baère

Purpose: An Asian study showed that gamma glutamyl transpeptidase (GGT) can predict survival after transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). This study was designed to validate in a European population this biomarker as an independent predictor of outcome after TACE of HCC and to determine a threshold value for clinical use. CardioVascular and Interventional Radiology October 2012, Volume 35, Issue 5, pp 1102-1108. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

01 octubre 2012

CVIR. Treating and Downstaging Hepatocellular Carcinoma in the Caudate Lobe with Yttrium-90 Radioembolization

Saad M. Ibrahim, Laura Kulik, Talia Baker, Robert K. Ryu, Mary F. Mulcahy, Michael Abecassis, Riad Salem, Robert J. Lewandowski

Purpose: This study was designed to determine the technical feasibility, safety, efficacy, and potential to downstage patients to within transplantation criteria when treating patients with hepatocellular carcinoma (HCC) of the caudate lobe using Y90 radioembolization. CardioVascular and Interventional Radiology October 2012, Volume 35, Issue 5, pp 1094-1101. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

01 diciembre 2012

CVIR. Origins of Feeding Arteries of Hepatocellular Carcinoma Located Near the Umbilical Fissure of the Left Hepatic Lobe: Angiographic Evaluation

Shiro Miyayama, Masashi Yamashiro, Yoshihiro Shibata, Masahiro Hashimoto, Miki Yoshida, Kazunobu Tsuji, Fumihito Toshima, Osamu Matsui

Purpose: To analyze the origins of the feeding arteries of hepatocellular carcinomas (HCCs) near the umbilical fissure of the left hepatic lobe. CardioVascular and Interventional Radiology December 2012, Volume 35, Issue 6, pp 1380-1387. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

01 diciembre 2012

CVIR. Radioembolization After Portal Vein Embolization in a Patient with Multifocal Hepatocellular Carcinoma

Mark C. Burgmans, Farah G. Irani, Wan Ying Chan, Terence K. Teo, Yung Hsiang Kao, Anthony S.W. Goh, Pierce K. Chow, Richard H. Lo

Abstract: Radioembolization is an effective locoregional therapy for patients with intermediate or advanced stage hepatocellular carcinoma (HCC). It has been shown that radioembolization is safe in patients with portal vein thrombosis. This case report describes safe radioembolization after portal vein embolization in a patient with multifocal HCC. CardioVascular and Interventional Radiology December 2012, Volume 35, Issue 6, pp 1519-1523. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012

01 diciembre 2012

CVIR. Hepatocellular Carcinoma Supplied From the Short Gastric Artery: Treatment With Chemoembolization

Ung Bae Jeon, Jun Woo Lee, Seung Kug Baik, Tae Un Kim, Ki Seok Choo, Kun Il Kim, Yong-Woo Kim, Tae-Yong Moon

Abstract: We report a case of transcatheter arterial chemoembolization (TACE) to treat hepatocellular carcinoma (HCC) that was supplied by the short gastric artery. A 67-year-old woman with two nodular HCCs underwent repeated TACE. One of the nodules was supplied by the short gastric artery. CardioVascular and Interventional Radiology December 2012, Volume 35, Issue 6, pp 1512-1514. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012

01 mayo 2012

CVIR. Embolization of Incompetent Pelvic Veins for the Treatment of Recurrent Varicose Veins in Lower Limbs and Pelvic Congestion Syndrome

Luis Meneses, Mario Fava, Pía Diaz, Marcelo Andía, Cristian Tejos, Pablo Irarrazabal, Sergio Uribe

Purpose: We present our experience with embolization of incompetent pelvic veins (IPV) in women with recurrence of varicose veins (VV) in lower limbs, as well as symptoms of pelvic congestion syndrome (PCS), after first surgery. In addition, we evaluated the effects of embolization in decreasing the symptoms of VV before surgery as well as its effects on PCS symptoms. CardioVascular and Interventional Radiology May 2012. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012

01 octubre 2012

CVIR. Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases

Ricarda Seidensticker, Timm Denecke, Patrick Kraus, Max Seidensticker, Konrad Mohnike, Jörg Fahlke, Erika Kettner, Bert Hildebrandt, Oliver Dudeck, Maciej Pech, Holger Amthauer, Jens Ricke

Purpose: This study was designed to evaluate overall survival after radioembolization or best supportive care (BSC) in patients with chemotherapy-refractory liver-dominant metastatic colorectal cancer (mCRC). CardioVascular and Interventional Radiology October 2012, Volume 35, Issue 5, pp 1066-1073. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

01 octubre 2012

CVIR. Use of Cryoablation and Osteoplasty Reinforced with Kirschner Wires in the Treatment of Femoral Metastasis

Ahmed Kamel Abdel-Aal, Edgar S. Underwood, Souheil Saddekni

Purpose: We report the case of a 43-year-old man with metastatic breast carcinoma to the proximal right femur resulting in severe painful pathological fracture. The patient experienced severe pain despite large doses of analgesia, resulting in impaired functionality and quality of life. The patient had significant comorbidities, making him a high surgical risk. CardioVascular and Interventional Radiology October 2012, Volume 35, Issue 5, pp 1211-1215. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012

01 diciembre 2012

CVIR. Percutaneous Stabilization of Impending Pathological Fracture of the Proximal Femur

Frederic Deschamps, Geoffroy Farouil, Antoine Hakime, Christophe Teriitehau, Ali Barah, Thierry de Baere

Objective: Percutaneous osteosynthesis plus cementoplasty (POPC) is a minimally invasive technique that has never been reported before and that we have prospectively evaluated for patients with impending pathological fracture of the proximal femur. CardioVascular and Interventional Radiology December 2012, Volume 35, Issue 6, pp 1428-1432. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

01 diciembre 2012

CVIR. Irinotecan Loaded in Eluting Beads: Preclinical Assessment in a Rabbit VX2 Liver Tumor Model

Pramod P. Rao, Florentina Pascale, Atman Seck, Anne Auperin, Laurence Drouard-Troalen, Frederic Deschamps, Christophe Teriitheau, Angelo Paci, Alban Denys, Pierre Bize, Thierry de Baere

Purpose: The purpose of this study was to study the pharmacokinetics of irinotecan injected intravenously, intra-arterially, or loaded onto a delivery platform. CardioVascular and Interventional Radiology December 2012, Volume 35, Issue 6, pp 1448-1459. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012

25 septiembre 2012

RADIOLOGY. MR Thermometry Analysis of Sonication Accuracy and Safety Margin of Volumetric MR Imaging–guided High-Intensity Focused Ultrasound Ablation of Symptomatic Uterine Fibroids

Young-sun Kim, MD, Hervé Trillaud, MD, Hyunchul Rhim, MD, Hyo K. Lim, MD, Willem Mali, MD, Marianne Voogt, MD, Jörg Barkhausen, MD, Thomas Eckey, MD, Max O. Köhler, PhD, Bilgin Keserci, PhD, Charles Mougenot, PhD, Shunmugavelu D. Sokka, PhD, Jouko Soini, PhD and Heikki J. Nieminen, PhD

Purpose: To evaluate the accuracy of the size and location of the ablation zone produced by volumetric magnetic resonance (MR) imaging–guided high-intensity focused ultrasound ablation of uterine fibroids on the basis of MR thermometric analysis and to assess the effects of a feedback control technique. Published online before print September 25, 2012, doi: 10.1148/radiol.12111194 November 2012 Radiology, 265, 627-637. Copyright © RSNA, 2012

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.